Estrogen receptor classification for hepatocellular carcinoma: Comparison with clinical staging systems

Journal of Clinical Oncology

Volumn 21, Issue 3, 2003, Pages 441-446

  Villa, Erica ^a   Colantoni, Alessandra ^a   Cammà, Calogero ^a   Grottola, Antonella ^a   Buttafoco, Paola ^a   Gelmini, Roberta ^a   Ferretti, Ilva ^a   Manenti, Federico ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ACCURACY; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; HUMAN; INTERMETHOD COMPARISON; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; WILD TYPE; ADULT; AGED; CLASSIFICATION; CLINICAL TRIAL; COMPARATIVE STUDY; FEMALE; GENE EXPRESSION REGULATION; GENETIC VARIABILITY; LIVER TUMOR; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; SURVIVAL;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTORS, ESTROGEN; SURVIVAL; VARIATION (GENETICS);

EID: 0037318187     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.11.051     Document Type: Article

References (19)

1. Barbara L, Benzi G, Gaiani S, et al: Natural history of small untreated hepatocellular carcinoma in cirrhosis: A multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology 16:132-137, 1992
2. Stuart KE, Anand AJ, Jenkins RL: Hepatocellular carcinoma in the United States: Prognostic features, treatment outcome, and survival. Cancer 77:2217-2222, 1996
3. Okuda K, Obata H, Nakalima Y, et al: Prognosis of primary hepatocellular carcinoma. Hepatology 4:3S-6S, 1984 (suppl)
4. Llovet JM, Bustamante J, Castells A, et al: Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials. Hepatology 29:62-67, 1999
5. The Cancer of the Liver Italian Program (CLIP) Investigators: Prospective validation of the CLIP score: A new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology 31:840-845, 2000
6. Chevret S, Trinchet JC, Mathieu D, et al: A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. J Hepatol 31:133-141, 1999
7. Llovet JM, Bruix J, Fuster J, et al: Liver transplantation for small hepatocellular carcinoma: The tumor-node-metastasis classification does not have prognostic power. Hepatology 27:1572-1577, 1998
8. el-Serag HB: Epidemiology of hepatocellular carcinoma. Clin Liver Dis 5:87-107, 2001
9. Colombo M: The natural history of hepatocellular carcinoma in western countries. Hepato-gastroenterology 45:1221-1225, 1998
10. Villa E, Camellini L, Dugani A, et al: Variant estrogen receptor messenger RNA species detected in human primary hepatocellular carcinoma. Cancer Res 55:498-500, 1995
11. Villa E, Dugani A, Fantoni E, et al: Type of estrogen receptor determines response to antiestrogen therapy in hepatocellular carcinoma. Cancer Res 56:3883-3885, 1996
12. Villa E, Moles A, Ferretti I, et al: Natural history of inoperable hepatocellular carcinoma: Estrogen receptors' status in the tumor is the strongest prognostic factor for survival. Hepatology 32:233-238, 2000
13. Villa E, Ferretti I, Grottola A, et al: Hormonal therapy with Megestrol in inoperable hepatocellular carcinoma characterised by variant estrogen receptors: A prospective, randomised, controlled trial. Br J Cancer 84:881-885, 2001
14. Pugh RNH, Murray-Lyon IM, Dawson JL, et al: Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646-664, 1973
15. Kaplan EL, Meier P: Non-parametric estimation for incomplete observation. Am Stat Assoc 53:457-481, 1958
16. Cox DR: Regression models and life tables (with discussion). J R Stat Soc B 34:187-220, 1972
17. Colantoni A, De Maria N, Manno M, et al: Biological features of hepatocellular carcinoma expressing variant estrogen receptor transcripts. J Hepatol 36:S183, 2002
18. Gozuacik D, Muratami Y, Saigo K, et al: Identification of human cancer-related genes by naturally occurring hepatitis B virus DNA tagging. Oncogene 20:6233-6240, 2001
19. Wu CG, Salvay DM, Forgues M, et al: Distinctive gene expression profiles associated with Hepatitis B virus x protein. Oncogene 20:3674-3682, 2001